Lan C K, Cheng D L, Lasserre R
Southeast Asian J Trop Med Public Health. 1986 Mar;17(1):119-24.
Pharmacokinetic properties of ceftriaxone, such as sustained tissue drug levels over 24 hours after a single injection; good penetration of the antibiotic into cells; significant biliary excretion as active unchanged compound and high potency against S. typhi, should make it possible to significantly shorten the treatment of typhoid fever. To test this hypothesis a pilot, open study was initiated. 17 adult patients suffering from uncomplicated typhoid or paratyphoid fever, documented by blood culture, were treated with 4g ceftriaxone once daily for three days (4 patients) or two days (15 patients). The cure rate of 17 assessable patients was 94.2% (one failure). One possible relapse was observed two months after treatment. It is to be noted that no patient in the study suffered from a severe form of the disease.
头孢曲松的药代动力学特性,如单次注射后24小时内组织药物水平持续维持;抗生素对细胞的良好穿透力;以活性未改变的化合物形式经胆汁大量排泄以及对伤寒杆菌的高效力,应使显著缩短伤寒热的治疗疗程成为可能。为验证这一假设,开展了一项初步的开放性研究。17例经血培养证实患有非复杂性伤寒或副伤寒热的成年患者,接受每日一次4克头孢曲松治疗,疗程为三天(4例患者)或两天(15例患者)。17例可评估患者的治愈率为94.2%(1例未治愈)。治疗后两个月观察到1例可能的复发。需要注意的是,该研究中没有患者患有严重形式的疾病。